A rational approach to select immunogenic peptides that induce IFN-γ response against Toxoplasma gondii in human leukocytes

• Bioinformatics predicted peptide sequences for HLA-A*02 high affinity and IFN γ production.
• 9mer peptides were selected for ELISPOT assays with human PBMCs.
• 4 peptides previously unidentified induced production of high IFN-γ levels.
• A rational strategy can be used to select new peptides as candidates for epitope-based vaccines.

The ideal vaccine to prevent toxoplasmosis in humans would comprise antigens that elicit a protective T cell type 1 response with high IFN-γ production. Here, we report the use of a bioinformatics pipeline to discover peptides based on biochemical characteristics that predict strong IFN-γ response by human leukocytes. We selected peptide sequences that previously were reported to induce IFN-γ to identify the biophysical characteristics that will predict HLA-A*02 high-affinity epitopes. We found that the protein motif pattern FL...L..[VL] was common in previously reported highly immunogenic sequences. We have selected new peptides with a length of 9 residues with affinities from 2 to 21 nM with peptide signal and transmembrane domains and predicted to be cleaved at the proteasome to perform ELISPOT assays with human leukocytes. Within 9 peptides with the highest scores for IFN-γ production, four peptides elicited IFN-γ levels in a range from 252 to 1763 SFC/1e6. Our pipeline uncovered Toxoplasma proteins with peptides that are processed by MHC class 1 in humans. Our results suggest that our rational strategy for the selection of immunogenic epitopes could be used to select peptides as candidates for inclusion in epitope-based vaccines.

Figure optionsDownload as PowerPoint slide